Menu
sharewise sharewise
Log in
Sign up
Log in
Sign up
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.
Top Performance

Predictions

sell
MacroGenics Inc.

Start price
Target price
Perf. (%)
€16.79
19.09.21
-
19.09.22
-79.51%
20.09.22

Probably not worthwhile Investment
Lokrim 
19.09.21 20%
sell
Abeona Therapeutics Inc.

Start price
Target price
Perf. (%)
€25.05
19.09.21
-
19.09.22
-85.23%
20.09.22

Growths faster than the competition
Risky Investment
Lokrim 
19.09.21 10%
sell
Celyad SA ADR

Start price
Target price
Perf. (%)
€3.58
19.09.21
-
19.09.22
-53.35%
20.09.22

Probably not worthwhile Investment
Lokrim 
19.09.21 10%
buy
Riot Blockchain Inc.

Start price
Target price
Perf. (%)
€15.70
07.02.22
-
07.02.23
-60.50%
19.09.22

Could be worthwhile Investment >10% per year
Very high cyclical dependencies
Gilbert 
07.02.22 0%
buy
Athersys Inc.

Start price
Target price
Perf. (%)
€2.21
15.09.22
€4.60
15.09.23
-15.60%
19.09.22

Could be very worthwhile Investment >20% year
DomRuinart 
15.09.22 50%
sell
Heat Biologics Inc.

Start price
Target price
Perf. (%)
€5.30
18.09.21
-
18.09.22
-63.56%
19.09.22

Risky Investment
High risks for its business
Dependend from few customers or products
Shooter 
18.09.21 50%
buy
Puma Biotechnology Inc.

Start price
Target price
Perf. (%)
€2.63
04.09.22
-
04.09.23
-6.99%
18.09.22

Could be worthwhile Investment >10% per year
thomasw 
04.09.22 50%
buy
Bayer AG

Start price
Target price
Perf. (%)
€54.25
14.09.22
€65.00
14.09.23
-3.93%
17.09.22

JosefS 
14.09.22 50%
buy
Bayer AG

Start price
Target price
Perf. (%)
€54.25
14.09.22
€65.00
14.09.23
-3.93%
17.09.22

JosefS 
14.09.22 50%
buy
Valneva SE

Start price
Target price
Perf. (%)
€11.82
14.09.21
-
14.09.22
-29.36%
15.09.22

Joe130978 
14.09.21 50%
buy
Valneva SE

Start price
Target price
Perf. (%)
€11.82
14.09.21
€30.00
14.09.22
-29.36%
15.09.22

Could be worthwhile Investment >10% per year
Top 10 in its market
Future proof or reliable business model
Standard Investments for future growth
Sargnagel 
14.09.21 0%
buy
Assembly Biosciences Inc.

Start price
Target price
Perf. (%)
€2.76
12.09.21
€3.00
12.09.22
-24.82%
13.09.22

Could be worthwhile Investment >10% per year
melinda 
12.09.21 50%
buy
Seres Therapeutics Inc

Start price
Target price
Perf. (%)
€4.99
12.09.21
€8.00
12.09.22
36.81%
13.09.22

Could be worthwhile Investment >10% per year
melinda 
12.09.21 50%
sell
Inventiva SA

Start price
Target price
Perf. (%)
€11.54
10.09.21
€8.00
10.09.22
-63.65%
11.09.22

Could be worthwhile Investment >10% per year
melinda 
10.09.21 50%
sell
Novavax Inc.

Start price
Target price
Perf. (%)
€39.31
09.08.22
€30.00
09.08.23
-20.37%
09.09.22

maria3 
09.08.22 50%
buy
Codexis Inc.

Start price
Target price
Perf. (%)
€34.80
05.11.21
€50.00
31.12.23
-79.99%
07.09.22

Could be very worthwhile Investment >20% year
IfYouCanDreamItYouCanDoIt 
05.11.21 70%
buy
Valneva SE

Start price
Target price
Perf. (%)
€24.64
16.12.21
€33.00
31.12.23
-67.02%
07.09.22

Could be very worthwhile Investment >20% year
IfYouCanDreamItYouCanDoIt 
16.12.21 60%
buy
Novavax Inc.

Start price
Target price
Perf. (%)
€202.35
31.08.21
€350.00
31.12.23
-85.81%
07.09.22

Could be worthwhile Investment >10% per year
IfYouCanDreamItYouCanDoIt 
31.08.21 60%
buy
Novavax Inc.

Start price
Target price
Perf. (%)
€212.55
05.09.21
€333.00
05.09.22
-85.70%
06.09.22

Top 10 in its market
Could be worthwhile Investment >10% per year
Leading role in innovation
Very Future proof/growth oriented business model
kostojunior 
05.09.21 80%
buy
MorphoSys AG

Start price
Target price
Perf. (%)
€30.80
08.01.22
-
08.01.26
-46.20%
05.09.22

Probably not worthwhile Investment
Lutz69 
08.01.22 50%
buy
MorphoSys AG

Start price
Target price
Perf. (%)
€30.80
08.01.22
-
08.01.26
-46.20%
05.09.22

Probably not worthwhile Investment
Lutz69 
08.01.22 50%
buy
Mirati Therapeutics Inc.

Start price
Target price
Perf. (%)
€76.50
21.08.22
€230.00
21.08.23
6.54%
04.09.22

Revenue growth >5% per year expected
EBIT growth >5% per year expected
Probably not worthwhile Investment
Lower EBIT Margin than peer group
Ruckelsbuckel 
21.08.22 50%
buy
Mediwound Ltd.

Start price
Target price
Perf. (%)
€1.97
13.08.22
€5.00
13.08.23
-6.09%
04.09.22

Could be very worthwhile Investment >20% year
Revenue growth > 30% per year expected
EBIT growth > 30% per year expected
Rising EBIT margin expected
Ruckelsbuckel 
13.08.22 60%
buy
Mediwound Ltd.

Start price
Target price
Perf. (%)
€1.99
22.08.22
€4.00
22.08.23
-7.04%
04.09.22

Could be worthwhile Investment >10% per year
Revenue growth >5% per year expected
EBIT growth >5% per year expected
Higher EBIT margin than peer group
Marianka 
22.08.22 50%
sell
Alnylam Pharmace.

Start price
Target price
Perf. (%)
€214.90
21.08.22
€87.00
21.08.23
-3.44%
04.09.22

Probably not worthwhile Investment
Revenue decline/stagnation expected
EBIT decline/stagnation expected
Lower EBIT Margin than peer group
dimontalban 
21.08.22 60%